According to Lipocine's latest financial reports the company's current EPS (TTM) is -1,92 โฌ. In 2022 the company made an earnings per share (EPS) of -1,77 โฌ a decrease over its 2021 EPS that were of -0,15 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -2,09 โฌ | 18.1% |
2022 | -1,77 โฌ | 1094.12% |
2021 | -0,15 โฌ | -97.5% |
2020 | -5,91 โฌ | -20% |
2019 | -7,39 โฌ | -9.09% |
2018 | -8,13 โฌ | -47.12% |
2017 | -15,38 โฌ | -0% |
2016 | -15,38 โฌ | -4.93% |
2015 | -16,17 โฌ | -31.63% |
2014 | -23,66 โฌ | 74.47% |
2013 | -13,56 โฌ | -99.35% |
2012 | -2.080 โฌ |